Asian Phytoceuticals PCLBKK:APCO-R 62 ROC (Joel Greenblatt) % is 98.32% as of Mar. 2026, which is 18% above its 10-year median of 82.98. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.61. The stock has 4 warning signs investors should review. Among 1,972 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks better than 93.91% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Asian Phytoceuticals PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 98.32%.
The historical rank and industry rank for Asian Phytoceuticals PCL's ROC (Joel Greenblatt) % or its related term are showing as below:
BKK:APCO-R'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 63.56 Med: 82.98 Max: 146.97
Current: 78.47
During the past 13 years, Asian Phytoceuticals PCL's highest ROC (Joel Greenblatt) % was 146.97%. The lowest was 63.56%. And the median was 82.98%.
BKK:APCO-R's ROC (Joel Greenblatt) % is ranked better than 93.91% of 1972
companies
in the Consumer Packaged Goods industry
Industry Median: 11.99
vs BKK:APCO-R: 78.47
Asian Phytoceuticals PCL's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 2.50% per year.
Asian Phytoceuticals PCL (BKK:APCO-R) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Asian Phytoceuticals PCL ROC (Joel Greenblatt) % Related Terms
Asian Phytoceuticals PCL ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Asian Phytoceuticals PCL's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL ROC (Joel Greenblatt) % Chart
BKK:APCO-R vs PG, CL, KVUE: ROC (Joel Greenblatt) % Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's ROC (Joel Greenblatt) % falls into.
Asian Phytoceuticals PCL ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 98.32% mean?
Asian Phytoceuticals PCL (BKK:APCO-R) has a ROC (Joel Greenblatt) % of 98.32% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Asian Phytoceuticals PCL and its competitors. This is 18% above median its historical median of 82.98. Over the past decade, Asian Phytoceuticals PCL's ROC (Joel Greenblatt) % has ranged from 63.56 to 146.97. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #120 out of 1972 companies in the Consumer Packaged Goods industry, placing it in the top 6.1%.
Is Asian Phytoceuticals PCL's ROC (Joel Greenblatt) % too high?
Asian Phytoceuticals PCL's current ROC (Joel Greenblatt) % of 98.32% is 18% above median its 10-year median of 82.98. Over the past 10 years, this metric has ranged from a low of 63.56 to a high of 146.97. The Consumer Packaged Goods industry median ROC (Joel Greenblatt) % is 11.99. Asian Phytoceuticals PCL's value of 98.32% is 720% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #120 out of 1972 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's ROC (Joel Greenblatt) % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #120 out of 1972 companies for ROC (Joel Greenblatt) %. This places Asian Phytoceuticals PCL in the top 6% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 11.99. Asian Phytoceuticals PCL's value of 98.32% is 720% above this benchmark. Historically, Asian Phytoceuticals PCL's own ROC (Joel Greenblatt) % has ranged from 63.56 to 146.97 over the past decade. While the company's 10-year median is 82.98 vs. the industry median of 11.99, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 11.99, based on 1,972 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current ROC (Joel Greenblatt) % of 98.32% is 720% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 11.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current ROC (Joel Greenblatt) % is 98.32%, which is 18% above median its own 10-year median of 82.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current ROC (Joel Greenblatt) % of 98.32%. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current ROC (Joel Greenblatt) % is 98.32%, which is 18% above median its 10-year median of 82.98 and 720% above the Consumer Packaged Goods industry median of 11.99. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current ROC (Joel Greenblatt) % is 98.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
ROC (Joel Greenblatt) %: 98.32% (18% above median its 10-year median of 82.98)
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
Industry Position: 720% above the Consumer Packaged Goods median (#120 of 1972)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
